The board of directors for Thousand Oaks biopharmaceutical giant Amgen approved at $1.15 dividend for the third quarter on July 28.
Shareholders of record at the close of day on Aug. 17 will be paid the dividend on Sept. 8.
• Contact Marissa Nall at mnall@pacbiztimes.com.